Research summary ·
Efficacy and safety of flow diverters for the treatment of intracranial aneurysms: a systematic review and meta-analysis.
Written based on 1 research study on PubMed, searched on 13 Nov 2026.
What was studied
This review looked at flow diverters for brain aneurysms. It covered many brands of this device. The team searched PubMed, EMBASE and Cochrane up to April 11, 2023. They pooled the results of 104 studies. They checked how often the treatment worked and closed the aneurysm. They also checked for harms, such as bleeding, clots, bursting and death.
What they found
The procedure worked in nearly all cases. Few aneurysms needed to be treated again. Many aneurysms were fully or nearly fully closed at 6 months. Closure rates were higher at 12 months. The p64 brand had high rates of full closure at both times. It also needed few rescue treatments. The aneurysm burst in few cases, and few people died. Some people had the vessel narrow again inside the stent. The abstract also gives first-month rates of some harms. These include bleeding, clots and deaths linked to the brain.
What it means for patients
The authors say flow diverters often succeed and close brain aneurysms well. They say the safety looks good. In their view, bursting and death were rare after this treatment. They also say these results need care before people rely on them.
Why it is not certain yet
The authors themselves urge caution. The studies differed a lot in their patients and care. Most were studies that just watched people in one group. These studies had no comparison group. The search only went up to April 11, 2023. A review can only be as good as the studies in it.
Source
Efficacy and safety of flow diverters for the treatment of intracranial aneurysms: a systematic review and meta-analysis.
PubMed · PMID 42639123We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Brain aneurysm publications